These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 5000515)

  • 1. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.
    Couch RB; Douglas RG; Fedson DS; Kasel JA
    J Infect Dis; 1971 Nov; 124(5):473-80. PubMed ID: 5000515
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.
    Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL
    J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals.
    Schulman JL; Kilbourne ED
    J Infect Dis; 1971 Nov; 124(5):463-72. PubMed ID: 5115670
    [No Abstract]   [Full Text] [Related]  

  • 4. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.
    Kilbourne ED; Schulman JL; Schild GC; Schloer G; Swanson J; Bucher D
    J Infect Dis; 1971 Nov; 124(5):449-62. PubMed ID: 5115669
    [No Abstract]   [Full Text] [Related]  

  • 5. Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.
    Murphy BR; Chalhub EG; Nusinoff SR; Chanock RM
    J Infect Dis; 1972 Aug; 126(2):170-8. PubMed ID: 4626544
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines.
    Mogabgab WJ; Leiderman E
    JAMA; 1970 Mar; 211(10):1672-6. PubMed ID: 4984268
    [No Abstract]   [Full Text] [Related]  

  • 7. Specificity of respiratory secretion antibody against influenza virus.
    Waldman RH; Wigley FM Small PA
    J Immunol; 1970 Dec; 105(6):1477-83. PubMed ID: 4320734
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response in man to influenza virus neuraminidase following influenza.
    Kilbourne ED; Christenson WN; Sande M
    J Virol; 1968 Jul; 2(7):761-2. PubMed ID: 5723531
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenicity of influenza vaccine from bovine cell cultures.
    Leiderman E; Mogabgab WJ
    Appl Microbiol; 1969 Oct; 18(4):596-600. PubMed ID: 4905036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to influenza virus enzyme in man.
    Davenport FM; Minuse E; Hennessy AV
    Arch Environ Health; 1970 Sep; 21(3):307-11. PubMed ID: 5504431
    [No Abstract]   [Full Text] [Related]  

  • 13. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza viral neuraminidase: the forgotten antigen.
    Johansson BE; Cox MM
    Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of species and organ-specific features of tissue systems on the reactogenic and immunogenic properties of influenza virus.
    Gorev NE
    Acta Virol; 1975 Jan; 19(1):41-6. PubMed ID: 235196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of partial immunity to influenza by a neuraminidase-specific vaccine.
    Couch RB; Kasel JA; Gerin JL; Schulman JL; Kilbourne ED
    J Infect Dis; 1974 Apr; 129(4):411-20. PubMed ID: 4593871
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adaptation of freshly isolated strains of influenza viruses. I. Neuraminidase activity].
    Brydak L; Semkow R; Zgorzelska K
    Med Dosw Mikrobiol; 1971; 23(1):33-8. PubMed ID: 5103919
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of inactivated influenza vaccine to protect an aged population.
    D'Alessio DJ; Cox PM; Dick EC
    JAMA; 1969 Oct; 210(3):485-9. PubMed ID: 5394377
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a live, attenuated recombinant influenza vaccine in high school children.
    Schiff GM; Linnemann CC; shea L; Lange B; Rotte T
    Infect Immun; 1975 Apr; 11(4):754-7. PubMed ID: 1168170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.